# Everolimus restores gefitinib sensitivity in resistant non-small cell lung cancer cell lines

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/everolimus-restores-gefitinib-sensitivity-in-resistant-non-small-cell-lung/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Silvia La Monica,Maricla Galetti,Roberta Alfieri,Andrea Cavazzoni,Andrea Ardizzoni,Marcello Tiseo,Marzia Capelletti,Matteo Goldoni,Sara Tagliaferri,Antonio Mutti,Claudia Fumarola,Mara Bonelli,Daniele Generali,Pier Giorgio Petronini |
| Citations | 83 |
| DOI | 10.1016/j.bcp.2009.04.033 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://hal.science/hal-00497268 |
| OpenAlex ID | https://openalex.org/W2024086004 |
| PMID | 19427302 |
| Type | article |
| Year | 2009 |

## Paper authors

- [Silvia La Monica](https://scholariq.org/researchers/silvia-la-monica/)

## Paper journal

- [Biochemical Pharmacology](https://scholariq.org/journals/biochemical-pharmacology/)

## Paper primary topic

- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)

## Paper topics

- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Mechanisms and Therapy](https://scholariq.org/topics/cancer-mechanisms-and-therapy/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.